- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/5395 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
Patent holdings for IPC class A61K 31/5395
Total number of patents in this class: 186
10-year publication summary
|
15
|
9
|
16
|
13
|
20
|
10
|
16
|
5
|
11
|
7
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bow River LLC | 23 |
16 |
| Bayer AG | 3509 |
8 |
| The Broad Institute, Inc. | 1983 |
8 |
| Principia Biopharma Inc. | 249 |
7 |
| The Regents of the University of California | 20802 |
6 |
| Dana-Farber Cancer Institute, Inc. | 2668 |
5 |
| Abbvie Inc. | 1822 |
4 |
| Dechra Veterinary Products LLC | 90 |
4 |
| BASF SE | 21310 |
3 |
| Bayer Pharma AG | 1010 |
3 |
| Eli Lilly and Company | 4101 |
3 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3007 |
3 |
| USpharma Ltd. | 20 |
3 |
| Merck Sharp & Dohme LLC | 3736 |
3 |
| Zevra Denmark A/S | 58 |
3 |
| Merck Sharp & Dohme Corp. | 2183 |
2 |
| Abbott Products GmbH | 8 |
2 |
| Lawrence Livermore National Security, LLC | 1977 |
2 |
| University of Florida Research Foundation, Inc. | 4184 |
2 |
| Asahi Kasei Pharma Corporation | 115 |
2 |
| Other owners | 97 |